-
2
-
-
0029934215
-
Management of pulmonary disease in patients with cystic fibrosis
-
Ramsey BW,. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996; 335: 179-188.
-
(1996)
N Engl J Med
, vol.335
, pp. 179-188
-
-
Ramsey, B.W.1
-
3
-
-
33744454666
-
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
-
Bergen PJ, Jian Li, Rayner CR, Nation RL,. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006; 50: 1953-1958.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 1953-1958
-
-
Bergen, P.J.1
Jian, L.2
Rayner, C.R.3
Nation, R.L.4
-
4
-
-
33747362870
-
Colistin: The re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections
-
Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL,. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis 2006; 6: 589-601.
-
(2006)
Lancet Infect Dis
, vol.6
, pp. 589-601
-
-
Li, J.1
Nation, R.L.2
Turnidge, J.D.3
Milne, R.W.4
Coulthard, K.5
Rayner, C.R.6
Paterson, D.L.7
-
6
-
-
84872835202
-
-
Coly-Mycin M Parenteral, P.I. Parkedale Pharmaceuticals, Inc.
-
Coly-Mycin M Parenteral, P.I. Parkedale Pharmaceuticals, Inc. 2006.
-
(2006)
-
-
-
7
-
-
84872860349
-
-
Colomycin Injection P.I. Forest Laboratories UK, Limited 2010
-
Colomycin Injection P.I. Forest Laboratories UK, Limited. 2010.
-
-
-
-
8
-
-
70350446684
-
Cystic fibrosis pulmonary guidelines: Treatment of pulmonary exacerbations
-
Clinical Practice Guidelines for Pulmonary Therapies Committee
-
Flume PA, Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC, Clinical Practice Guidelines for Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009; 180: 802-808.
-
(2009)
Am J Respir Crit Care Med
, vol.180
, pp. 802-808
-
-
Flume, P.A.1
Flume, P.A.2
Mogayzel, Jr.P.J.3
Robinson, K.A.4
Goss, C.H.5
Rosenblatt, R.L.6
Kuhn, R.J.7
Marshall, B.C.8
-
11
-
-
0033773012
-
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: A European consensus
-
Doring G, Conway SP, Heijerman HG, Hodson ME, Høiby N, Smyth A, Touw DJ,. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000; 16: 749-767.
-
(2000)
Eur Respir J
, vol.16
, pp. 749-767
-
-
Doring, G.1
Conway, S.P.2
Heijerman, H.G.3
Hodson, M.E.4
Høiby, N.5
Smyth, A.6
Touw, D.J.7
-
12
-
-
0011970183
-
Antimicrobial agents: Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents
-
Limbird JGHaLE, editor. New York: McGraw-Hill
-
Chambers HF,. Antimicrobial agents: Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents. In:, Limbird JGHaLE, editor. Goodman and Gilman's The pharmacological basis of therapeutics. New York: McGraw-Hill; 2001. pp 1239-1272.
-
(2001)
Goodman and Gilman's the Pharmacological Basis of Therapeutics
, pp. 1239-1272
-
-
Chambers, H.F.1
-
13
-
-
0035013931
-
The pharmacokinetics of colistin in patients with cystic fibrosis
-
Reed MD, Stern RC, O'Riordan MA, Blumer JL,. The pharmacokinetics of colistin in patients with cystic fibrosis. J Clin Pharmacol 2001; 41: 645-654.
-
(2001)
J Clin Pharmacol
, vol.41
, pp. 645-654
-
-
Reed, M.D.1
Stern, R.C.2
O'Riordan, M.A.3
Blumer, J.L.4
-
14
-
-
0348149151
-
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis
-
Li J, Kingsley C, Milne R, Nation RL, Conway S, Peckham D, Etherington C, Turnidge J,. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. J Antimicrob Chemother 2003; 52: 987-992.
-
(2003)
J Antimicrob Chemother
, vol.52
, pp. 987-992
-
-
Li, J.1
Kingsley, C.2
Milne, R.3
Nation, R.L.4
Conway, S.5
Peckham, D.6
Etherington, C.7
Turnidge, J.8
-
16
-
-
40049095690
-
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: Studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
-
Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW,. Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. J Antimicrob Chemother 2008; 61: 636-642.
-
(2008)
J Antimicrob Chemother
, vol.61
, pp. 636-642
-
-
Bergen, P.J.1
Li, J.2
Nation, R.L.3
Turnidge, J.D.4
Coulthard, K.5
Milne, R.W.6
-
17
-
-
0035118424
-
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
-
Li J, Turnidge J, Milne R, Nation RL, Coulthard K,. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 2001; 45: 781-785.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 781-785
-
-
Li, J.1
Turnidge, J.2
Milne, R.3
Nation, R.L.4
Coulthard, K.5
-
18
-
-
0030783691
-
Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis
-
Conway SP, Pond MN, Watson A, Etherington C, Robey HL, Goldman MH,. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis. Thorax 1997; 52: 987-993.
-
(1997)
Thorax
, vol.52
, pp. 987-993
-
-
Conway, S.P.1
Pond, M.N.2
Watson, A.3
Etherington, C.4
Robey, H.L.5
Goldman, M.H.6
-
19
-
-
0033761572
-
Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis
-
Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M,. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis. Ann Pharmacother 2000; 34: 1238-1242.
-
(2000)
Ann Pharmacother
, vol.34
, pp. 1238-1242
-
-
Conway, S.P.1
Etherington, C.2
Munday, J.3
Goldman, M.H.4
Strong, J.J.5
Wootton, M.6
-
20
-
-
84860195528
-
In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in pseudomonas aeruginosa biofilm infection
-
Hengzhuang W, Hengzhuang W, Wu H, Ciofu O, Song Z, Høiby N,. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in pseudomonas aeruginosa biofilm infection. Antimicrob Agents Chemother 2012; 56: 2683-2690.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 2683-2690
-
-
Hengzhuang, W.1
Hengzhuang, W.2
Wu, H.3
Ciofu, O.4
Song, Z.5
Høiby, N.6
-
22
-
-
77956119797
-
Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model
-
Bergen PJ, Bulitta JB, Forrest A, Tsuji BT, Li J, Nation RL,. Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model. Antimicrob Agents Chemother 2010; 54: 3783-3789.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 3783-3789
-
-
Bergen, P.J.1
Bulitta, J.B.2
Forrest, A.3
Tsuji, B.T.4
Li, J.5
Nation, R.L.6
-
23
-
-
77149178390
-
Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models
-
Dudhani RV, Turnidge JD, Coulthard K, Milne RW, Rayner CR, Li J, Nation RL,. Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. Antimicrob Agents Chemother 2010; 54: 1117-1124.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 1117-1124
-
-
Dudhani, R.V.1
Turnidge, J.D.2
Coulthard, K.3
Milne, R.W.4
Rayner, C.R.5
Li, J.6
Nation, R.L.7
-
24
-
-
79959248672
-
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients
-
Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP, Forrest A, Nation RL,. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother 2011; 55: 3284-3294.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 3284-3294
-
-
Garonzik, S.M.1
Li, J.2
Thamlikitkul, V.3
Paterson, D.L.4
Shoham, S.5
Jacob, J.6
Silveira, F.P.7
Forrest, A.8
Nation, R.L.9
-
25
-
-
67749145541
-
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria
-
Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother 2009; 53: 3430-3436.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3430-3436
-
-
Plachouras, D.1
Karvanen, M.2
Friberg, L.E.3
Papadomichelakis, E.4
Antoniadou, A.5
Tsangaris, I.6
Karaiskos, I.7
Poulakou, G.8
Kontopidou, F.9
Armaganidis, A.10
-
26
-
-
0031657976
-
Four years' experience of intravenous colomycin in an adult cystic fibrosis unit
-
Ledson MJ, Gallagher MJ, Cowperthwaite C, Convery RP, Walshaw MJ,. Four years' experience of intravenous colomycin in an adult cystic fibrosis unit. Eur Respir J 1998; 12: 592-594.
-
(1998)
Eur Respir J
, vol.12
, pp. 592-594
-
-
Ledson, M.J.1
Gallagher, M.J.2
Cowperthwaite, C.3
Convery, R.P.4
Walshaw, M.J.5
-
27
-
-
10344219968
-
Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use
-
Al-Aloul M, Miller H, Alapati S, Stockton P, Ledson MJ, Walshaw MJ,. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol 2005; 39: 15-20.
-
(2005)
Pediatr Pulmonol
, vol.39
, pp. 15-20
-
-
Al-Aloul, M.1
Miller, H.2
Alapati, S.3
Stockton, P.4
Ledson, M.J.5
Walshaw, M.J.6
-
28
-
-
0025876185
-
Toxicity of colistin in cystic fibrosis patients
-
Bosso JA, Liptak CA, Seilheimer DK, Harrison GM,. Toxicity of colistin in cystic fibrosis patients. DICP: Ann Pharmacother 1991; 25: 1168-1170.
-
(1991)
DICP: Ann Pharmacother
, vol.25
, pp. 1168-1170
-
-
Bosso, J.A.1
Liptak, C.A.2
Seilheimer, D.K.3
Harrison, G.M.4
|